Blueprint Medicines Corporation (BPMC) is trading at $129.46 up 0.14% over the past 24 hours. Its Galaxy Score is 47.5, LunarCrush's combined measure of market and social performance. Over the last 24 hours it has seen 2.8K engagements and 3 posts with 100% positive social sentiment.
AI summary: Blueprint Medicines Corporation (BPMC) is a biotech company seeing a rally driven by BLU-808 progress and merger chatter. Near-term price action likely to consolidate as momentum wanes despite BLU-808 optimism; the rally appears overextended and price may pull back before resuming longer-term strength.